Isoxsuprine hydrochloride in the horse: A review

Journal of Veterinary Pharmacology and Therapeutics

Volumn 25, Issue 2, 2002, Pages 81-87

  Erkert, R S ^b   Macallister, C G ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACEPROMAZINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ISOXSUPRINE; MELANIN; PLACEBO; PRAZOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD VISCOSITY; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFECT; HORSE DISEASE; LAMINITIS; NAVICULAR SYNDROME; NONHUMAN; PATHOGENESIS; PLASMA HALF LIFE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGREGATION; URINARY EXCRETION; UTERUS RELAXATION; VASODILATATION;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; FOOT DISEASES; HORSE DISEASES; HORSES; INFUSIONS, INTRAVENOUS; ISOXSUPRINE; LAMENESS, ANIMAL; OSTEITIS; TARSAL BONES; VASODILATOR AGENTS;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0036094127     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2002.00386.x     Document Type: Review

References (39)

1. Red blood cell deformability influences platelets-vessel wall interaction in flowing blood
2. Effects of acepromazine maleate, isoxsuprine hydrochloride and prazosin hydrochloride on laminar microcirculatory blood flow in healthy horses
3. Reactivity of equine palmar digital arteries and veins to vasodilating agents
4. Investigations on the stereoselective action of isoxsuprine on α- and β-adrenoceptors in equine common digital artery
5. Affinity of isoxsuprine for adrenoreceptors in equine digital artery and implications for vasodilatory action
6. Principles of drug therapy
7. The pharmacologic basis for treatment of developmental and acute laminitis
8. Mechanism of action of isoprenaline, isoxsuprine, terbutaline and orciprenaline on gravid human isolated myometrium. Influence of the neuronal uptake process
9. Drugs acting on adrenoreceptors
10. Effect of an isoxsuprine-resin preparation on blood flow in the equine thoracic limb
11. The effects of intravenous isoxsuprine on blood viscosity in patients with occlusive peripheral arterial disease
12. Antagonism in isolated equine digital vessels of contraction induced by epinephrine in the presence of hydrocortisone and an aqueous extract of black walnut (Juglans nigra)
13. The autonomic nervous system; the adrenal medulla
14. Character and duration of pharmacological effects of intravenous isoxsuprine
15. Absence of detectable pharmacological effects after oral administration of isoxsuprine
16. The pharmacologic control of excessive uterine activity with isoxsuprine
17. Postprandial arterial vasodilation in the equine distal thoracic limb
18. The effect of oral isoxsuprine and pentoxifylline on digital and laminar blood flow in healthy horses
19. A Pharmacokinetic Study of Isoxsuprine in the Horse
20. Circulatory and blood gas changes accompanying the development and treatment of induced laminitis
21. Treatment and pathogenesis of navicular disease ('syndrome') in horses
22. Cardiovascular and pharmacokinetic effects of isoxsuprine in the horse
23. Tocolytic drugs for use in veterinary obstetrics
24. Synthesis of β-phenylethylamine derivatives. IV. A new vasodilator
25. Pulmonary edema associated with isoxsuprine therapy
26. Equine laminitis: Its development post alimentary carbohydrate overload coincides with increased sublamellar blood flow
27. Prolonged presence of isoxsuprine in equine serum after oral administration
28. Experience with isoxsuprine in the treatment of sickle cell crisis: A proposed mechanism of action
29. Studies on isoxsuprine hydrochloride for the treatment of navicular disease
30. Use of a new vasodilator agent in management of peripheral arterial insufficiency
31. Nitric oxide release accounts for insulin's effects in humans
32. Lameness
33. Decreased viscosity of human erythrocyte suspension induced by chlorpromazine and isoxsuprine
34. Melanin affinity: A possible explanation of isoxsuprine retention in the horse
35. The evaluation of isoxsuprine hydrochloride for the treatment of navicular disease: A double blind study
36. Metrenperone treatment of navicular disease in horses compared with isoxsuprine: A clinical study
37. A double-blind placebo controlled cross-over study in patients with peripheral vascular diseases, using a new capillary viscometer
38. Controlled clinical studies in Europe with isoxsuprine hydrochloride for the treatment of navicular disease and sesamoidosis in horses
39. Gross, histological, and histomorphometric features of the navicular bone and related structures in the horse